Labopharm Inc. (Nasdaq: DDSS) 41.5% HIGHER; announced that RYZOLT, its once-daily formulation of the analgesic tramadol, has been approved by the FDA. RYZOLT is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.

Gilat Satellite Networks Ltd. (Nasdaq: GILT) 35.7% HIGHER; announced that the lengthy negotiations with the Ministry of Communications in Colombia have led to signature of new agreements for the provision of services under the Compartel I, Compartel II and Telecentros projects which were awarded to Gilat’s Colombian subsidiaries in